Recruiting INTERVENTIONAL NCT07420803

A Study Of Auricular Transcutaneous Vagus Nerve Stimulation In Chronic Dizziness

Efficacy Of Auricular Transcutaneous Vagus Nerve Stimulation In Treating Chronic Dizziness

Sponsor: Mayo Clinic

Conditions Chronic Dizziness Persistent Postural Perceptual Dizziness

Interventions Auricular transcutaneous vagus nerve stimulation Sham Device

Updated 2 times since 2026 Last updated: Apr 14, 2026 Started: Mar 23, 2026 Primary completion: Mar 1, 2027 Completion: Mar 1, 2027

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Chronic Dizziness and Persistent Postural Perceptual Dizziness and is currently actively recruiting participants. Mayo Clinic leads this study, which shows 2 recorded versions since 2026 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

2 versions recorded

Apr 18, 2026 — Present [daily]

Recruiting

Phase: NA → None
Feb 2026 — Apr 2026 [monthly]

Recruiting NA

First recorded

Eligibility Summary

The purpose of this study is to measure the change in dizziness, as measured by change in Dizziness Handicap Inventory (DHI) score, following a 4-week treatment period with auricular transcutaneous vagus nerve stimulation (aTVNS).

Contact Information

Sponsor contact:

Mayo Clinic

Data source: ClinicalTrials.gov

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Jacksonville, United States